VXRT: Vaxart Inc Company Profile & Statistics

About

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick injury. Its development programs are oral tablet vaccines designed to protect against norovirus, seasonal influenza and respiratory syncytial virus, as well as a therapeutic vaccine for human papillomavirus. Vaxart, Inc., formerly known as Aviragen Therapeutics, is based in South San Francisco, United States.

Info & Links

CEO

Michael J. Finney

Headquarters

170 Harbor Way, Suite 300
South San Francisco, CA 94080, UNITED STATES

Auditor

WithumSmith+Brown, PC

Share holders

2,264

Employees

109

Vaxart Inc Statistics

Valuation Measures

Market Capitalization²

125.11M

Enterprise Value

103.08M

Enterprise Value/EBITDA(ttm)

-1.63

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

8.04

Price to Book(mrq)

1.97

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-431.61%

Profit Margin(ttm)

-549.41%

Return on Equity(ttm)

-110.46%

Return on Invested Capital(ttm)

-115.05%

Return on Assets(ttm)

-62.78%

Income Statement

Revenue(ttm)

16.76M

Revenue Per Share(ttm)

0.07

Gross Profit(ttm)

16.76M

EBITDA(ttm)³

-63.38M

Net Income Available to Common(ttm)

-72.34M

Diluted EPS(ttm)

-0.41

Share Statistics

Beta (5Y Monthly)

0.62

52-Week Change

-24.86%

S&P 500 52-Week Change

24.55%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

227.48M

Dividend Yield

0.00%

Float⁴

221.57M

% Held by Insiders

2.60%

% Held by Institutions

18.05%

Balance Sheet

Total Cash(mrq)

58.71M

Total Cash Per Share(mrq)

0.26

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.83%

Quick Ratio(mrq)

0.83%

Book Value Per Share(mrq)

0.30

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.16

Free Cash Flow(ytd)

-37.93M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

VXRT

Vaxart Inc

Vaxart Inc Profile